SAFETY INFORMATION
| Signal word | Warning |
|---|---|
| Pictogram(s) |
 Exclamation Mark Irritant GHS07 |
| GHS Hazard Statements |
H302:Acute toxicity,oral |
| Precautionary Statement Codes |
P280:Wear protective gloves/protective clothing/eye protection/face protection. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. |
COMPUTED DESCRIPTORS
| Molecular Weight | 325.63 g/mol |
|---|---|
| XLogP3 | 5.5 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 4 |
| Exact Mass | 323.99166 g/mol |
| Monoisotopic Mass | 323.99166 g/mol |
| Topological Polar Surface Area | 9.2 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 241 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
Description
5-bromo-2-chloro-4'-ethoxydiphenylmethane is the important intermediate of synthetic antidiabetic medicine dapagliflozin (Dapagliflozin).
RELATED SUPPLIERS
Stoichiometry Pharma Chemical Specialties
1Y
product:5-bromo-2-chloro-4'ethoxydiphenylmethane (BCEDP) 461432-23-5 99%